Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice

被引:84
作者
Croquelois, A
Blindenbacher, A
Terracciano, L
Wang, XY
Langer, I
Radtke, F
Heim, MH
机构
[1] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland
[3] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland
[4] Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland
[5] Univ Lausanne, Sch Med, Div Hypertens, Lausanne, Switzerland
[6] Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland
关键词
D O I
10.1002/hep.20571
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The discovery that the human Jagged1 gene (JAG1) is the Alagille syndrome disease gene indicated that Notch signaling has an important role in bile duct homeostasis. The functional study of this signaling pathway has been difficult because mice with targeted mutations in Jagged1, Notch1, or Notch2 have an embryonic lethal phenotype. We have previously generated mice with inducible Notch1 disruption using an interferon-inducible Cre-recombinase transgene in combination with the loxP flanked Notch1 gene. We used this conditional Notch1 knockout mouse model to investigate the role of Notch1 signaling in liver cell proliferation and differentiation. Deletion of Notch1 did not result in bile duct paucity, but, surprisingly, resulted in a continuous proliferation of hepatocytes. In conclusion, within weeks after Notch1 inactivation, the mice developed nodular regenerative hyperplasia without vascular changes in the liver.
引用
收藏
页码:487 / 496
页数:10
相关论文
共 35 条
[1]   SYNDROMIC PAUCITY OF INTERLOBULAR BILE-DUCTS (ALAGILLE SYNDROME OR ARTERIOHEPATIC DYSPLASIA) - REVIEW OF 80 CASES [J].
ALAGILLE, D ;
ESTRADA, A ;
HADCHOUEL, M ;
GAUTIER, M ;
ODIEVRE, M ;
DOMMERGUES, JP .
JOURNAL OF PEDIATRICS, 1987, 110 (02) :195-200
[2]  
Alagille D, 1996, CLIN INVEST MED, V19, P325
[3]   Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[4]  
Bläker H, 1999, GENE CHROMOSOME CANC, V25, P399
[5]  
CONLON RA, 1995, DEVELOPMENT, V121, P1533
[6]  
de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
[7]  
GERMAIN L, 1988, CANCER RES, V48, P4909
[8]  
Hamada Y, 1999, DEVELOPMENT, V126, P3415
[9]  
Higgins GM, 1931, ARCH PATHOL, V12, P186
[10]  
Koch A, 1999, CANCER RES, V59, P269